| 摘要 |
PURPOSE:To obtain the subject pharmaceutical, containing cysteine and taurine as active ingredients and capable of further imparting persistence while maintaining well-known drug effects of the cysteine, exhibiting hepatic strengthening action and inhibiting occurrence of various hepatopathy other than acetaminophen hepatopathy. CONSTITUTION:An inhibitor containing cysteine and taurine as active ingredients. In use, the active ingredients are mixed with liquid or solid adjuvant ingredients, e.g. excipient, binder or diluent, for formulating a pharmaceutical and orally or parenterally administered in an optional dosage form, such as powder, granule, tablet, capsule or injection. The mixing ratio of the cysteine to the taurine used is about 1:3 molar ratio. |
